Found 4363 articles for: ""
Oral Tazarotene and Oral Pimecrolimus: Novel Oral Therapies in Development for Psoriasis
March 2004 | Volume 3 | Issue 2 | Original Article | 141 | Copyright © March 2004
Psoriasis is a chronic skin disorder that affects approximately 2% of the US and European population. Over the last several years, one of the major focuses in psoriasis research has been the developm...
Read MoreBotulinum Toxin Type A: Fine -Tuning Treatment of Facial Nerve Injury
March 2004 | Volume 3 | Issue 2 | Original Article | 133 | Copyright © March 2004
Treatment of patients following facial nerve injury can be daunting. A multitude of procedures have been developed to treat the paralyzed face. As patients recover from facial nerve injuries, a varie...
Read MoreClinical Trial Review
January 2004 | Volume 3 | Issue 1 | Features | 105 | Copyright © January 2004
Washington Whispers
January 2004 | Volume 3 | Issue 1 | Features | 101 | Copyright © January 2004
Pipeline Previews
January 2004 | Volume 3 | Issue 1 | Features | 97 | Copyright © January 2004
Genetic Testing for Inherited Predisposition to Melanoma: Has the Time Come?
January 2004 | Volume 3 | Issue 1 | Case Reports | 93 | Copyright © January 2004
Primary Cutaneous B-cell Lymphoma in a 74-Year-Old Caucasian Male
January 2004 | Volume 3 | Issue 1 | Case Reports | 88 | Copyright © January 2004
Primary cutaneous B-cell lymphoma is an uncommon neoplasm with classification schemes that may be confusing, but with clinical presentations that are relatively consistent. Clinical exam and history ...
Read MoreVenous Thrombosis Occurring After Initiation of Thalidomide for the Treatment of Cicatricial Pemphigoid
January 2004 | Volume 3 | Issue 1 | Case Reports | 83 | Copyright © January 2004
Thalidomide is increasingly being used for the treatment of a variety of dermatologic conditions. Some of the risks associated with thalidomide use, however, are still being uncovered. Increased inci...
Read MoreCutaneous Vasculitis Secondary to Ramipril
January 2004 | Volume 3 | Issue 1 | Case Reports | 81 | Copyright © January 2004
A 61-year-old patient who had been treated with lisinopril in the past without any problems was commenced on ramipril for left ventricular dysfunction. He developed a painful symmetrical purpuric eru...
Read MoreGeneralized Pustular Psoriasis Following Withdrawal of Efalizumab
January 2004 | Volume 3 | Issue 1 | Case Reports | 77 | Copyright © January 2004
Efalizumab is one of the new biologic therapies targeting T-lymphocyte activity for the treatment of chronic plaque psoriasis. Common adverse effects include headaches, nonspecific infection, nausea,...
Read MoreLocalized Heat Induced Urticaria: Report of a Case
January 2004 | Volume 3 | Issue 1 | Case Reports | 75 | Copyright © January 2004
Localized heat induced urticaria is a rare clinical entity. Other physical urticarial subtypes include cholinergic, solar, cold, aquagenic, vibratory, and dermatographic. It is characterized by a wel...
Read MoreImiquimod as a Possible Treatment for Keratoacanthoma
January 2004 | Volume 3 | Issue 1 | Case Reports | 71 | Copyright © January 2004
Imiquimod is an immune-response modifier that has the potential to be useful in many dermatological indications (Table 1). To date, the approved use is for condyloma acuminata; approval for use in tr...
Read MoreThe Nuances of Dealing with Cosmetic Patients
January 2004 | Volume 3 | Issue 1 | Original Article | 67 | Copyright © January 2004
Dermatologic Look- or Sound-Alike Medications
January 2004 | Volume 3 | Issue 1 | Original Article | 61 | Copyright © January 2004
Medication errors contribute substantially to patient injury and death, with 25% of these errors attributed to drug names that look or sound alike. This article was written to heighten the awareness ...
Read MorePicaridin: A New Insect Repellent
January 2004 | Volume 3 | Issue 1 | Original Article | 59 | Copyright © January 2004
Picaridin is a new insect repellent that is comparable in effect and less irritating than diethyl toluamide (deet). Its activity and effects are reviewed in this article....
Read MoreOnychomycosis: Classification and Diagnosis
January 2004 | Volume 3 | Issue 1 | Original Article | 51 | Copyright © January 2004
Onychomycosis is a common infection of the nail predominantly caused by anthropophilic dermatophytes, and to a lesser extent by yeasts (Candida species) and non-dermatophyte molds. The treatment of o...
Read MorePhotorejuvenation with Intense Pulsed Light: Results of a Multi-Center Study
January 2004 | Volume 3 | Issue 1 | Original Article | 41 | Copyright © January 2004
This multi-center study evaluating the role of Intense Pulsed Light (IPL) in the non-ablative rejuvenation of Type I and Type II photoaged skin study was conducted in order to evaluate the clinical e...
Read MoreImpact of Efalizumab on Psoriasis-Specific Patient-Reported Outcomes
January 2004 | Volume 3 | Issue 1 | Original Article | 27 | Copyright © January 2004
The objective of this study was to document the disease burden associated with moderate to severe plaque psoriasis, and assess the impact of efalizumab psoriasis treatment in improving patient-report...
Read MoreTopical Treatment of Actinic Keratosis with Fluorouracil: Is Irritation Associated with Efficacy?
January 2004 | Volume 3 | Issue 1 | Original Article | 21 | Copyright © January 2004
Actinic keratoses (AKs) are common dysplastic epidermal lesions that share clinical, histologic, and molecular features with squamous cell carcinoma. Therapeutic options include destructive modalitie...
Read MoreRedefining Clinical Response in Psoriasis: Targeting the Pathological Basis of Disease
January 2004 | Volume 3 | Issue 1 | Original Article | 13 | Copyright © January 2004
Psoriasis is a chronic inflammatory disease of the skin that can have a major effect on patient quality of life. Conventional psoriasis treatments, often identified empirically, fail to meet the clin...
Read More